Illumina, Inc. (ILMN)
USD 71.27
(-3.07%)
USD 71.27
(-3.07%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 10.11 Billion USD | -17.47% |
| 2022 | 12.25 Billion USD | -19.48% |
| 2021 | 15.21 Billion USD | 100.62% |
| 2020 | 7.58 Billion USD | 3.68% |
| 2019 | 7.31 Billion USD | 5.13% |
| 2018 | 6.95 Billion USD | 32.38% |
| 2017 | 5.25 Billion USD | 22.81% |
| 2016 | 4.28 Billion USD | 16.08% |
| 2015 | 3.68 Billion USD | 10.5% |
| 2014 | 3.33 Billion USD | 10.55% |
| 2013 | 3.01 Billion USD | 17.65% |
| 2012 | 2.56 Billion USD | 16.86% |
| 2011 | 2.19 Billion USD | 19.4% |
| 2010 | 1.83 Billion USD | 28.61% |
| 2009 | 1.42 Billion USD | 3.84% |
| 2008 | 1.37 Billion USD | 39.42% |
| 2007 | 987.73 Million USD | 228.6% |
| 2006 | 300.58 Million USD | 198.76% |
| 2005 | 100.61 Million USD | 6.01% |
| 2004 | 94.9 Million USD | -4.36% |
| 2003 | 99.23 Million USD | -18.6% |
| 2002 | 121.9 Million USD | -0.46% |
| 2001 | 122.46 Million USD | -7.78% |
| 2000 | 132.79 Million USD | 291.78% |
| 1999 | 33.89 Million USD | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q2 | 6.08 Billion USD | -39.43% |
| 2024 Q1 | 10.04 Billion USD | -0.7% |
| 2024 Q3 | 6.01 Billion USD | -1.1% |
| 2023 Q1 | 11.81 Billion USD | -3.6% |
| 2023 FY | 10.11 Billion USD | -17.47% |
| 2023 Q2 | 11.77 Billion USD | -0.31% |
| 2023 Q3 | 10.12 Billion USD | -14.03% |
| 2023 Q4 | 10.11 Billion USD | -0.11% |
| 2022 Q1 | 15.27 Billion USD | 0.37% |
| 2022 Q4 | 12.25 Billion USD | 8.85% |
| 2022 Q3 | 11.25 Billion USD | -27.14% |
| 2022 FY | 12.25 Billion USD | -19.48% |
| 2022 Q2 | 15.44 Billion USD | 1.14% |
| 2021 Q2 | 8.67 Billion USD | -0.91% |
| 2021 Q4 | 15.21 Billion USD | 1.02% |
| 2021 Q1 | 8.75 Billion USD | 15.43% |
| 2021 FY | 15.21 Billion USD | 100.62% |
| 2021 Q3 | 15.06 Billion USD | 73.64% |
| 2020 Q3 | 7.4 Billion USD | 2.15% |
| 2020 Q1 | 7.26 Billion USD | -0.75% |
| 2020 Q2 | 7.24 Billion USD | -0.18% |
| 2020 Q4 | 7.58 Billion USD | 2.44% |
| 2020 FY | 7.58 Billion USD | 3.68% |
| 2019 FY | 7.31 Billion USD | 5.13% |
| 2019 Q4 | 7.31 Billion USD | 3.2% |
| 2019 Q1 | 7.39 Billion USD | 6.19% |
| 2019 Q2 | 6.97 Billion USD | -5.64% |
| 2019 Q3 | 7.08 Billion USD | 1.66% |
| 2018 Q3 | 6.75 Billion USD | 15.52% |
| 2018 Q1 | 5.54 Billion USD | 5.42% |
| 2018 Q2 | 5.85 Billion USD | 5.58% |
| 2018 FY | 6.95 Billion USD | 32.38% |
| 2018 Q4 | 6.95 Billion USD | 2.96% |
| 2017 FY | 5.25 Billion USD | 22.81% |
| 2017 Q4 | 5.25 Billion USD | 4.18% |
| 2017 Q3 | 5.04 Billion USD | 3.87% |
| 2017 Q2 | 4.85 Billion USD | 5.65% |
| 2017 Q1 | 4.59 Billion USD | 7.41% |
| 2016 FY | 4.28 Billion USD | 16.08% |
| 2016 Q1 | 3.79 Billion USD | 2.87% |
| 2016 Q3 | 4.22 Billion USD | 6.09% |
| 2016 Q2 | 3.98 Billion USD | 5.04% |
| 2016 Q4 | 4.28 Billion USD | 1.25% |
| 2015 Q2 | 3.7 Billion USD | 5.83% |
| 2015 FY | 3.68 Billion USD | 10.5% |
| 2015 Q3 | 3.73 Billion USD | 0.82% |
| 2015 Q4 | 3.68 Billion USD | -1.23% |
| 2015 Q1 | 3.49 Billion USD | 4.84% |
| 2014 Q4 | 3.33 Billion USD | 1.81% |
| 2014 Q2 | 3.03 Billion USD | -0.61% |
| 2014 Q3 | 3.27 Billion USD | 8.01% |
| 2014 FY | 3.33 Billion USD | 10.55% |
| 2014 Q1 | 3.05 Billion USD | 1.14% |
| 2013 FY | 3.01 Billion USD | 17.65% |
| 2013 Q3 | 2.81 Billion USD | -0.2% |
| 2013 Q2 | 2.82 Billion USD | 2.88% |
| 2013 Q4 | 3.01 Billion USD | 7.14% |
| 2013 Q1 | 2.74 Billion USD | 6.94% |
| 2012 Q4 | 2.56 Billion USD | 5.25% |
| 2012 FY | 2.56 Billion USD | 16.86% |
| 2012 Q3 | 2.43 Billion USD | 3.8% |
| 2012 Q1 | 2.3 Billion USD | 4.81% |
| 2012 Q2 | 2.34 Billion USD | 2.05% |
| 2011 Q3 | 2.14 Billion USD | -4.87% |
| 2011 Q4 | 2.19 Billion USD | 2.27% |
| 2011 FY | 2.19 Billion USD | 19.4% |
| 2011 Q2 | 2.25 Billion USD | 6.3% |
| 2011 Q1 | 2.12 Billion USD | 15.44% |
| 2010 Q1 | 1.5 Billion USD | 5.26% |
| 2010 Q4 | 1.83 Billion USD | 6.6% |
| 2010 FY | 1.83 Billion USD | 28.61% |
| 2010 Q3 | 1.72 Billion USD | 5.08% |
| 2010 Q2 | 1.64 Billion USD | 9.08% |
| 2009 Q1 | 1.37 Billion USD | -0.33% |
| 2009 Q2 | 1.47 Billion USD | 7.62% |
| 2009 Q3 | 1.54 Billion USD | 4.37% |
| 2009 Q4 | 1.42 Billion USD | -7.25% |
| 2009 FY | 1.42 Billion USD | 3.84% |
| 2008 Q2 | 992.68 Million USD | 6.08% |
| 2008 Q1 | 935.75 Million USD | -5.26% |
| 2008 FY | 1.37 Billion USD | 39.42% |
| 2008 Q4 | 1.37 Billion USD | 1.16% |
| 2008 Q3 | 1.36 Billion USD | 37.14% |
| 2007 Q4 | 987.73 Million USD | 21.91% |
| 2007 Q3 | 810.2 Million USD | 4.74% |
| 2007 Q2 | 773.57 Million USD | 4.14% |
| 2007 Q1 | 742.83 Million USD | 147.13% |
| 2007 FY | 987.73 Million USD | 228.6% |
| 2006 FY | 300.58 Million USD | 198.76% |
| 2006 Q4 | 300.58 Million USD | 17.2% |
| 2006 Q3 | 256.47 Million USD | 11.05% |
| 2006 Q2 | 230.95 Million USD | 105.24% |
| 2006 Q1 | 112.52 Million USD | 11.84% |
| 2005 FY | 100.61 Million USD | 6.01% |
| 2005 Q3 | 97.02 Million USD | 6.32% |
| 2005 Q1 | 93.78 Million USD | -1.19% |
| 2005 Q2 | 91.25 Million USD | -2.69% |
| 2005 Q4 | 100.61 Million USD | 3.69% |
| 2004 Q1 | 98.22 Million USD | -1.02% |
| 2004 FY | 94.9 Million USD | -4.36% |
| 2004 Q4 | 94.9 Million USD | 3.08% |
| 2004 Q3 | 92.07 Million USD | -26.52% |
| 2004 Q2 | 125.3 Million USD | 27.57% |
| 2003 Q4 | 99.23 Million USD | -6.63% |
| 2003 FY | 99.23 Million USD | -18.6% |
| 2003 Q1 | 115.21 Million USD | -5.49% |
| 2003 Q2 | 106.53 Million USD | -7.54% |
| 2003 Q3 | 106.27 Million USD | -0.24% |
| 2002 FY | 121.9 Million USD | -0.46% |
| 2002 Q1 | 140.55 Million USD | 14.77% |
| 2002 Q2 | 133.61 Million USD | -4.94% |
| 2002 Q4 | 121.9 Million USD | -5.11% |
| 2002 Q3 | 128.46 Million USD | -3.85% |
| 2001 Q1 | 130.69 Million USD | -1.58% |
| 2001 Q3 | 127.54 Million USD | -2.0% |
| 2001 FY | 122.46 Million USD | -7.78% |
| 2001 Q4 | 122.46 Million USD | -3.98% |
| 2001 Q2 | 130.15 Million USD | -0.41% |
| 2000 Q1 | 34.43 Million USD | 0.0% |
| 2000 Q4 | 132.79 Million USD | -1.61% |
| 2000 FY | 132.79 Million USD | 291.78% |
| 2000 Q3 | 134.96 Million USD | 300.56% |
| 2000 Q2 | 33.69 Million USD | -2.14% |
| 1999 FY | 33.89 Million USD | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| Aclaris Therapeutics, Inc. | 197.4 Million USD | -5021.957% |
| Applied DNA Sciences, Inc. | 13.65 Million USD | -73964.703% |
| Aspira Women's Health Inc. | 6.26 Million USD | -161365.985% |
| Biodesix, Inc. | 99.09 Million USD | -10103.237% |
| BioNexus Gene Lab Corp. | 11.39 Million USD | -88594.593% |
| bioAffinity Technologies, Inc. | 8.22 Million USD | -122881.646% |
| bioAffinity Technologies, Inc. | 8.22 Million USD | -122881.646% |
| Bionano Genomics, Inc. | 214.4 Million USD | -4615.864% |
| CareDx, Inc | 484.61 Million USD | -1986.398% |
| Check-Cap Ltd. | 25.01 Million USD | -40316.517% |
| Castle Biosciences, Inc. | 477.81 Million USD | -2016.109% |
| DarioHealth Corp. | 96.38 Million USD | -10389.786% |
| Exact Sciences Corporation | 6.47 Billion USD | -56.243% |
| Fulgent Genetics, Inc. | 1.27 Billion USD | -694.198% |
| Guardant Health, Inc. | 1.78 Billion USD | -465.992% |
| ICON Public Limited Company | 16.98 Billion USD | 40.488% |
| IDEXX Laboratories, Inc. | 3.25 Billion USD | -210.161% |
| Intelligent Bio Solutions Inc. | 13.77 Million USD | -73280.51% |
| iSpecimen Inc. | 15.81 Million USD | -63816.255% |
| Standard BioTools Inc. | 323.06 Million USD | -3029.691% |
| MDxHealth SA | 129.13 Million USD | -7729.972% |
| 23andMe Holding Co. | 395.16 Million USD | -2458.665% |
| Medpace Holdings, Inc. | 1.65 Billion USD | -510.263% |
| Myriad Genetics, Inc. | 1.19 Billion USD | -743.497% |
| Mainz Biomed B.V. | 15.4 Million USD | -65517.377% |
| ENDRA Life Sciences Inc. | 6.75 Million USD | -149600.643% |
| NeoGenomics, Inc. | 1.68 Billion USD | -501.405% |
| Neogen Corporation | 4.58 Billion USD | -120.564% |
| Inotiv, Inc. | 856.53 Million USD | -1080.461% |
| Natera, Inc. | 1.45 Billion USD | -593.901% |
| OpGen, Inc. | 1.88 Million USD | -537069.403% |
| OPKO Health, Inc. | 2.01 Billion USD | -402.61% |
| Psychemedics Corporation | 13.27 Million USD | -76094.424% |
| Prenetics Global Limited | 254.17 Million USD | -3878.038% |
| Prenetics Global Limited | 254.17 Million USD | -3878.038% |
| Precipio, Inc. | 18.1 Million USD | -55758.792% |
| Personalis, Inc. | 225.09 Million USD | -4391.801% |
| RadNet, Inc. | 2.88 Billion USD | -250.262% |
| Sera Prognostics, Inc. | 95.44 Million USD | -10493.98% |
| Sotera Health Company | 3.13 Billion USD | -222.992% |
| Neuronetics, Inc. | 115.83 Million USD | -8629.097% |
| Star Equity Holdings, Inc. | 86.97 Million USD | -11525.313% |
| Star Equity Holdings, Inc. | 86.97 Million USD | -11525.313% |
| Trinity Biotech plc | 59.43 Million USD | -16911.862% |
| T2 Biosystems, Inc. | 34.79 Million USD | -28957.103% |
| Twist Bioscience Corporation | 776.4 Million USD | -1202.288% |
| Exagen Inc. | 56.94 Million USD | -17656.041% |